Alignment Healthcare Beheer
Beheer criteriumcontroles 3/4
De CEO Alignment Healthcare is John Kao, benoemd in Jan2014, heeft een ambtstermijn van 10.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 14.30M, bestaande uit 5.5% salaris en 94.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 1.51% van de aandelen van het bedrijf, ter waarde $ 35.13M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.6 jaar en 9.5 jaar.
Belangrijke informatie
John Kao
Algemeen directeur
US$14.3m
Totale compensatie
| Percentage CEO-salaris | 5.5% |
| Dienstverband CEO | 10.8yrs |
| Eigendom CEO | 1.5% |
| Management gemiddelde ambtstermijn | 5.6yrs |
| Gemiddelde ambtstermijn bestuur | 9.5yrs |
Recente managementupdates
Recent updates
A Piece Of The Puzzle Missing From Alignment Healthcare, Inc.'s (NASDAQ:ALHC) 30% Share Price Climb
Nov 07
Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Intrinsic Value Is Potentially 73% Above Its Share Price
Oct 14Even With A 30% Surge, Cautious Investors Are Not Rewarding Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Performance Completely
Sep 12Alignment Healthcare (NASDAQ:ALHC) Has Debt But No Earnings; Should You Worry?
Sep 10Earnings Update: Here's Why Analysts Just Lifted Their Alignment Healthcare, Inc. (NASDAQ:ALHC) Price Target To US$9.55
Aug 04Market Might Still Lack Some Conviction On Alignment Healthcare, Inc. (NASDAQ:ALHC) Even After 27% Share Price Boost
Jul 18Is Now An Opportune Moment To Examine Alignment Healthcare, Inc. (NASDAQ:ALHC)?
Jul 12An Intrinsic Calculation For Alignment Healthcare, Inc. (NASDAQ:ALHC) Suggests It's 26% Undervalued
Jun 20The Market Lifts Alignment Healthcare, Inc. (NASDAQ:ALHC) Shares 37% But It Can Do More
May 30Is Alignment Healthcare (NASDAQ:ALHC) Weighed On By Its Debt Load?
Apr 19It's A Story Of Risk Vs Reward With Alignment Healthcare, Inc. (NASDAQ:ALHC)
Feb 24Does Alignment Healthcare (NASDAQ:ALHC) Have A Healthy Balance Sheet?
Jan 18Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Subdued P/S Might Signal An Opportunity
Nov 08Alignment Healthcare: Investors Should Align Themselves With Insiders
Oct 05Alignment Healthcare announces 9M shares secondary offering
Sep 15Alignment Healthcare completes debt refinancing
Sep 06Alignment Healthcare: This Next-Generation Medicare Startup Is Fully Valued
Aug 22Alignment Health Plan plans to expand into three Nevada counties
Jul 20Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$144m |
| Jun 30 2024 | n/a | n/a | -US$153m |
| Mar 31 2024 | n/a | n/a | -US$157m |
| Dec 31 2023 | US$14m | US$787k | -US$148m |
| Sep 30 2023 | n/a | n/a | -US$158m |
| Jun 30 2023 | n/a | n/a | -US$163m |
| Mar 31 2023 | n/a | n/a | -US$146m |
| Dec 31 2022 | US$34m | US$730k | -US$150m |
| Sep 30 2022 | n/a | n/a | -US$140m |
| Jun 30 2022 | n/a | n/a | -US$146m |
| Mar 31 2022 | n/a | n/a | -US$179m |
| Dec 31 2021 | US$46m | US$675k | -US$195m |
| Sep 30 2021 | n/a | n/a | -US$180m |
| Jun 30 2021 | n/a | n/a | -US$123m |
| Mar 31 2021 | n/a | n/a | -US$70m |
| Dec 31 2020 | US$4m | US$657k | -US$23m |
Compensatie versus markt: De totale vergoeding ($USD 14.30M ) John } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 5.43M ).
Compensatie versus inkomsten: De vergoeding van John is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
John Kao (62 yo)
10.8yrs
Tenure
US$14,296,476
Compensatie
Mr. John E. Kao is Chairman & CEO of Alignment Health Plan of Illinois, Inc. from 2022. Mr. Kao has been Director of Alignment Health Plan of Illinois, Inc. He is the Founder of Alignment Healthcare, Inc....
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 10.8yrs | US$14.30m | 1.51% $ 35.1m | |
| Chief Financial Officer | 7.8yrs | US$6.30m | 0.23% $ 5.4m | |
| Chief Medical Officer | 1.2yrs | US$3.06m | 0.072% $ 1.7m | |
| President of Health Markets & CEO of Health Plan | 10.8yrs | US$6.46m | 0.53% $ 12.2m | |
| Chief Experience Officer | less than a year | US$3.22m | 0.19% $ 4.3m | |
| Co-Founder & Chief Clinical Officer | no data | geen gegevens | 0.80% $ 18.6m | |
| Chief Accounting Officer and Senior Vice President | no data | geen gegevens | geen gegevens | |
| Chief Information Officer | 4.2yrs | geen gegevens | 0.10% $ 2.3m | |
| Chief Legal & Administrative Officer | 1.3yrs | geen gegevens | 0.026% $ 613.3k | |
| Chief Human Resources Officer | less than a year | geen gegevens | geen gegevens | |
| Senior Vice President of Business Operations | 7.9yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Clinical Product | 7.1yrs | geen gegevens | geen gegevens |
5.6yrs
Gemiddelde duur
56yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van ALHC is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.6 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 10.8yrs | US$14.30m | 1.51% $ 35.1m | |
| Independent Director | 10.8yrs | US$270.00k | 0.045% $ 1.0m | |
| Independent Chairman of the Board | 10.8yrs | US$2.25m | 0.47% $ 10.8m | |
| Independent Director | 10.8yrs | US$270.00k | 0.045% $ 1.0m | |
| Independent Director | 7.8yrs | US$265.63k | 0.12% $ 2.9m | |
| Independent Director | 2.8yrs | US$260.00k | 0.021% $ 496.4k | |
| Independent Director | 2.8yrs | US$257.50k | 0.025% $ 584.3k | |
| Lead Independent Director | 3.9yrs | US$280.42k | 0.043% $ 1.0m | |
| Independent Director | 10.8yrs | US$250.00k | 0.16% $ 3.8m | |
| Member of Advisory Board | 8.1yrs | geen gegevens | geen gegevens |
9.5yrs
Gemiddelde duur
68.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van ALHC wordt beschouwd als ervaren (gemiddelde ambtstermijn 9.5 jaar).